NCT07040800

Brief Summary

This cross-sectional observational study will assess adherence to previously prescribed medication in patients admitted to inpatient treatment at the scientific medical center. When filling out the questionnaire, the previously prescribed pharmacotherapy, the regularity of medication intake and the presence of side effects of drug treatment, if any, according to their medical history will be clarified.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
5,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Feb 2025

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 19, 2025

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

June 9, 2025

Completed
18 days until next milestone

First Posted

Study publicly available on registry

June 27, 2025

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 19, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 19, 2026

Completed
Last Updated

June 27, 2025

Status Verified

June 1, 2025

Enrollment Period

1 year

First QC Date

June 9, 2025

Last Update Submit

June 26, 2025

Conditions

Cardiovascular Diseases

Keywords

drug therapymedical recommendationscommitment

Outcome Measures

Primary Outcomes (1)

  • Proportion of patients with NSEPh adherence score ≥3 (i.e., complete secondary or complete primary non-commitment) at baseline

    Commitment to treatment was determined using the National Society of Evidence-Based Pharmacotherapy (NSEPh) adherence scale. Based on the scores obtained, patients are categorized as follows: * 0 points - full adherence * 1 point - partial (incomplete) non-commitment, unintentional violations * 2 points - partial (incomplete) non-commitment, intentional violations (including self-medication) * 3 points - complete secondary non-commitment * 4 points - complete primary non-commitment The threshold for defining non-adherence was set at ≥3 points.

    Baseline

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

patients admitted to a multidisciplinary hospital

You may qualify if:

  • all patients admitted to the scientific center, signed patients' informed consent

You may not qualify if:

  • patient's unsigned informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National Medical Research Centre for Therapy and Preventive Medicine

Moscow, 109380, Russia

Location

MeSH Terms

Conditions

Cardiovascular Diseases

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Target Duration
1 Year
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 9, 2025

First Posted

June 27, 2025

Study Start

February 19, 2025

Primary Completion

February 19, 2026

Study Completion

February 19, 2026

Last Updated

June 27, 2025

Record last verified: 2025-06

Data Sharing

IPD Sharing
Will not share

Locations

RU(1)